Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 03/31/2020 (updated monthly) $1,018.1 (M)
Net Assets - Class R6 As of 04/30/2020 (updated monthly) $9.5 (M)

Positions As of 04/30/2020

Equity VS. NASDAQ Biotechnology Index

Fund Benchmark
Market CapitalizationAs of 04/30/2020 (updated monthly) $33,568.32(M) $41,664.64(M)
P/B RatioAs of 04/30/2020 (updated monthly) 6.00 5.11
P/E Ratio (12-mo Forward)As of 04/30/2020 (updated monthly) 17.12 16.51
Price to Cash FlowAs of 04/30/2020 (updated monthly) 17.89 15.11

Portfolio Details

Asset AllocationAs of 04/30/2020

[name] [value]
Equity 91.51%
Cash & Cash Equivalents 8.49%

Geographic BreakdownAs of 04/30/2020

[name] [value]
United States 79.28%
Cash & Cash Equivalents 8.49%
United Kingdom 3.77%
Netherlands 3.09%
Denmark 2.44%
Canada 1.68%
Switzerland 0.70%
Germany 0.55%

sector breakdownAs of 04/30/2020

[name] [value]
Biotechnology 76.12%
Pharmaceuticals 10.61%
Cash & Cash Equivalents 8.49%
Life Sciences Tools & Services 4.77%

TOP TEN HOLDINGSAs of 04/30/2020

Issuer Country Industry % of total
VERTEX PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 7.25%
AMGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 6.48%
GILEAD SCIENCES INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.73%
REGENERON PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.72%
ILLUMINA INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.77%
BIOGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.77%
IOVANCE BIOTHERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.88%
GW PHARMACEUTICALS PLC United Kingdom Pharmaceuticals, Biotechnology & Life Sciences 3.59%
PTC THERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.25%
DECIPHERA PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 2.45%

Market Capitalization BreakdownAs of 04/30/2020

[name] [value]
<2.0 Billion 16.73%
2.0-5.0 Billion 25.51%
5.0-10.0 Billion 15.01%
10.0-25.0 Billion 4.45%
25.0-50.0 Billion 10.43%
>50.0 Billion 27.52%
N/A 0.34%